Biosimilars - a new treatment pathway?
Inflectra, marketed by Hospira and Remsima, manufactured by Celltrion, are essentially the same infliximab biosimilar of the original product Remicade, made by Johnson & Johnson.
Inflectra, marketed by Hospira and Remsima, manufactured by Celltrion, are essentially the same infliximab biosimilar of the original product Remicade, made by Johnson & Johnson.